Jayne B. Hart - Nov 30, 2021 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
Chief People Officer
Signature
By: Nathan A. Smith For: Jayne B. Hart
Stock symbol
MYGN
Transactions as of
Nov 30, 2021
Transactions value $
$3,143
Form type
4
Date filed
12/1/2021, 05:19 PM
Previous filing
Oct 12, 2021
Next filing
Feb 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYGN Common Stock Award $3.14K +143 +0.1% $21.98 146K Nov 30, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Myriad Genetics, Inc. 2012 Employee Stock Purchase Plan, as amended, in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).